These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10418532)

  • 1. Carvedilol.
    Crysant SG
    Arch Fam Med; 1999; 8(4):295. PubMed ID: 10418532
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular hypertrophy regression during antihypertensive treatment.
    Eichstaedt H; Danne O; Schroeder RJ; Kreuz D
    Clin Investig; 1992; 70 Suppl 1():S79-86. PubMed ID: 1350490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1995 Jul; 16 Suppl F():38-42. PubMed ID: 8521883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W; Agrawal B
    Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T; Tatli E; Yuksel M
    Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
    Frishman WH; Henderson LS; Lukas MA
    Vasc Health Risk Manag; 2008; 4(6):1387-400. PubMed ID: 19337551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
    Franz IW; Agrawal B; Wiewel D; Ketelhut R
    Clin Investig; 1992; 70 Suppl 1():S53-7. PubMed ID: 1350485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
    Sica DA
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):59-64. PubMed ID: 15655391
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment.
    van Zwieten PA
    Clin Investig; 1992; 70 Suppl 1():S7-12. PubMed ID: 1350488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of carvedilol on left ventricular function and mass in hypertension.
    Why HJ; Richardson PJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S50-4. PubMed ID: 1378151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu
    Kardiologiia; 2003; 43(2):69-70. PubMed ID: 12913988
    [No Abstract]   [Full Text] [Related]  

  • 19. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.
    Fraga R; Franco FG; Roveda F; de Matos LN; Braga AM; Rondon MU; Rotta DR; Brum PC; Barretto AC; Middlekauff HR; Negrão CE
    Eur J Heart Fail; 2007; 9(6-7):630-6. PubMed ID: 17475552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.